Skip to content
Agentic OS
Menu

Intelligence / B2B SaaS / Technology Funding Register / ImmunoVec, Inc.

Fundingraised $12.7M14 Jul 2026

ImmunoVec, Inc.

14 Jul 2026: Raised $12.7M · Los Angeles, CA. Recorded in the SEC Form D data sets.

View the source record

Filed
14 Jul 2026
Location
Los Angeles, CA
State
California
Industry
Other Technology
Amount raised
$12.7M
Offering size
$15.0M
Revenue range
Decline to Disclose
Entity type
Corporation
Jurisdiction
Delaware
First sale
2026-06-29
Securities
Equity, Preferred Stock and Common Stock issuable upon conversion thereof. Total Offering Amount and Total Amount Sold include conversion of the previously issued convertible securities.
Investors so far
10
SEC CIK
0001914272
What this signal means

Companies buy in the months after they raise: new hires, new vendors, new markets.

  1. 349 added in the 30 days to 30 Sept 2026.
  2. 265 of them (27%) raised $5M or more.
Reach them with AOS

Find the decision makers at ImmunoVec, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.

Start free

More from California

Technology Funding Register

See all

Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by technology companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.